|
LAPTM4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.096380E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.725700E-02 |
| Normal-vs-Stage2 |
3.082300E-02 |
| Normal-vs-Stage3 |
1.991980E-04 |
| Normal-vs-Stage4 |
4.215300E-03 |
| Stage1-vs-Stage2 |
3.416800E-01 |
| Stage1-vs-Stage3 |
1.340390E-02 |
| Stage1-vs-Stage4 |
1.202640E-01 |
| Stage2-vs-Stage3 |
4.829400E-01 |
| Stage2-vs-Stage4 |
7.891000E-01 |
| Stage3-vs-Stage4 |
6.380400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.782750E-03 |
| Normal-vs-AfricanAmerican |
1.417320E-03 |
| Normal-vs-Asian |
4.801400E-01 |
| Caucasian-vs-AfricanAmerican |
3.172200E-01 |
| Caucasian-vs-Asian |
7.521800E-01 |
| AfricanAmerican-vs-Asian |
4.569000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.799900E-03 |
| Normal-vs-Female |
5.959200E-03 |
| Male-vs-Female |
9.993400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.515700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.660400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.118500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.600800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.334800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.030600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.695200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.978400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.599800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.762000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.066600E-01 |
| Normal-vs-Grade 2 |
1.213650E-01 |
| Normal-vs-Grade 3 |
1.482840E-03 |
| Normal-vs-Grade 4 |
5.97350000000052E-05 |
| Grade 1-vs-Grade 2 |
7.530600E-01 |
| Grade 1-vs-Grade 3 |
2.482000E-01 |
| Grade 1-vs-Grade 4 |
3.123800E-02 |
| Grade 2-vs-Grade 3 |
1.846200E-02 |
| Grade 2-vs-Grade 4 |
1.079580E-03 |
| Grade 3-vs-Grade 4 |
9.237900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.153400E-01 |
| Normal-vs-ccB subtype |
4.22779999997847E-06 |
| ccA subtype-vs-ccB subtype |
1.70340000005265E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.884400E-03 |
| Normal-vs-N1 |
6.639800E-03 |
| N0-vs-N1 |
2.427200E-01 |
|
|
